These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 16612060

  • 1. Economic evaluation of the familial cancer programme in Western Australia: predictive genetic testing for familial adenomatous polyposis and hereditary non-polyposis colorectal carcinoma.
    Breheny N, Geelhoed E, Goldblatt J, Ee H, O'Leary P.
    Community Genet; 2006; 9(2):98-106. PubMed ID: 16612060
    [Abstract] [Full Text] [Related]

  • 2. [Hereditary colorectal carcinoma: predictive diagnosis and genetic counseling].
    Mangold E, Friedl W, Propping P.
    Praxis (Bern 1994); 2001 Mar 22; 90(12):490-6. PubMed ID: 11324308
    [Abstract] [Full Text] [Related]

  • 3. [Familial colorectal cancer].
    Sunde LE, Bülow S, Bernstein IT.
    Ugeskr Laeger; 2006 Jun 12; 168(24):2369-73. PubMed ID: 16822423
    [Abstract] [Full Text] [Related]

  • 4. Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome.
    Al-Sukhni W, Aronson M, Gallinger S.
    Surg Clin North Am; 2008 Aug 12; 88(4):819-44, vii. PubMed ID: 18672142
    [Abstract] [Full Text] [Related]

  • 5. Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.
    Soravia C, Bapat B, Cohen Z.
    Schweiz Med Wochenschr; 1997 Apr 19; 127(16):682-90. PubMed ID: 9140167
    [Abstract] [Full Text] [Related]

  • 6. Inherited susceptibility to colorectal cancer.
    Rowley PT.
    Annu Rev Med; 2005 Apr 19; 56():539-54. PubMed ID: 15660526
    [Abstract] [Full Text] [Related]

  • 7. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
    Schofield L, Goldblatt J, Iacopetta B.
    Rural Remote Health; 2011 Apr 19; 11(4):1836. PubMed ID: 22188021
    [Abstract] [Full Text] [Related]

  • 8. The use of genetic testing in hereditary colorectal cancer syndromes: genetic testing in HNPCC, (A)FAP and MAP.
    Ramsoekh D, van Leerdam ME, Tops CM, Dooijes D, Steyerberg EW, Kuipers EJ, Wagner A.
    Clin Genet; 2007 Dec 19; 72(6):562-7. PubMed ID: 17922849
    [Abstract] [Full Text] [Related]

  • 9. Simple and complex genetics of colorectal cancer susceptibility.
    Baglioni S, Genuardi M.
    Am J Med Genet C Semin Med Genet; 2004 Aug 15; 129C(1):35-43. PubMed ID: 15264271
    [Abstract] [Full Text] [Related]

  • 10. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology.
    Batra S, Valdimarsdottir H, McGovern M, Itzkowitz S, Brown K.
    Am J Gastroenterol; 2002 Mar 15; 97(3):729-33. PubMed ID: 11922570
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers.
    Vasen HF, van Ballegooijen M, Buskens E, Kleibeuker JK, Taal BG, Griffioen G, Nagengast FM, Menko FH, Meera Khan P.
    Cancer; 1998 May 01; 82(9):1632-7. PubMed ID: 9576281
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 May 01; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 15. Cost effectiveness of a new strategy to identify HNPCC patients.
    Kievit W, de Bruin JH, Adang EM, Severens JL, Kleibeuker JH, Sijmons RH, Ruers TJ, Nagengast FM, Vasen HF, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N.
    Gut; 2005 Jan 01; 54(1):97-102. PubMed ID: 15591512
    [Abstract] [Full Text] [Related]

  • 16. Cohorts with familial disposition for colon cancers in chemoprevention trials.
    Burt RW.
    J Cell Biochem Suppl; 1996 Jan 01; 25():131-5. PubMed ID: 9027609
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness of surveillance programs for families at high and moderate risk of hereditary non-polyposis colorectal cancer.
    Olsen KR, Bojesen SE, Gerdes AM, Lindorff-Larsen K, Bernstein IT.
    Int J Technol Assess Health Care; 2007 Jan 01; 23(1):89-95. PubMed ID: 17234021
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.